Andersons pediatric cardiology 2329
Bạn đang xem bản rút gọn của tài liệu. Xem và tải ngay bản đầy đủ của tài liệu tại đây (78.2 KB, 3 trang )
morphologyof,822–823,822f
naturalhistoryof,831
innewborn/infancy
clinicalfeaturesof,828
physicalexaminationof,828–829
inolderchild
clinicalfeaturesof,828
physicalexaminationof,829
pathophysiologyof,828
surgicalinterventionfor,833–834
timingofinterventionfor,833,833b
Aortic-to-pulmonaryarterialcommunications
fifthaorticarchand,906–909
Aortic-to-pulmonaryarterialconfluence,906–907
Aortictranslocation,690–692,691f
Aorticvalve
congenitalanomaliesof,819–842
morphogenesisof,825–827,826f–827f
morphologyof,819–825
disease,chronicrheumaticheartdiseaseand,1027–1030,1030b,1031f
implantationof,interventionaltechniquesfor,263
overridingof,intetralogyofFallot,636
surgeryfor,1037
three-dimensionalechocardiographyof,314t
Aorticvalveapparatus,indiagnosticcatheterization,250
Aortopathies
inpediatriccardiology,1077–1085
inpregnancy,1447
recommendedscreeningfor,1543
Aortopulmonarycollateralembolization,inFontancirculation,1342
Aortopulmonarycollaterals,indiagnosticcatheterization,251
Aortopulmonarywindows,949–951,950f–951f
clinicalfeaturesof,951–952
interventionaltechniquesfor,269
investigationsof,952,953f
managementof,952–956,954f
Aortoventriculartunnels,956–958,957f–958f
clinicalfeaturesof,958
investigationsof,958–959,959f
managementof,959
Apicaltrabecularcomponent,ofventricles,4,5f
left,24,24f,28
ARBs,Adrenergicreceptorblockers
Areaunderthecurve(AUC),1429,1430f
ARF,Acuterheumaticfever
Arrhythmias,137
additionaltestingfor,358
inadultswithcongenitalheartdisease,356–357
ambulatorymonitoringof,357–358
atrial,interatrialcommunicationand,514
cardiacMRIin,358
incardiactumors,965
documentationof,357–358
eventmonitorsof,358
exercisetestingfor,358,401
followingsurgicalcorrectionoftetralogyofFallot,648
Fontancirculation,1324–1329,1324f
atrialfibrillationin,1328
atrialtachyarrhythmiasin,1327–1328
bradycardiaandpacingin,1325,1325f–1326f
catheterablation,roleof,1328–1329
implantablecardioverter-defibrillatorsin,1325–1326
intraatrialreentranttachycardiasin,1327–1328,1327f–1328f
functionalcardiacabnormalities,449–450
ininterstagemanagement,1309
laboratoryevaluationsof,358
recordingmethodsof,357–358
insuperiorcavopulmonaryconnection,1299
supraventricular,341–349
symptomsof,357
ventricular,350–351
Arrhythmogenicrightventricularcardiomyopathy,1146b,1161–1163
cardiopulmonaryexercisetestingin,1162
clinicalfeaturesof,1162
clinicaloutcomesof,1161
definitionof,1161
echocardiographyin,1162
electrocardiographyin,1162
ambulatory,1162
signal-averaged,1162
epidemiologyof,1161
etiologyof,1161–1162
exercisetestingin,1162
magneticresonanceimagingin,1162
managementof,1162–1163
pathologyof,1162
Arterialduct,755–773
anatomyof,757–773
closureof
biologyof,195
ininfantsbornwithextremelylowweight,195–196
embryologyof,756–757,756f–757f
fetalcirculationand,87
hemodynamicallysignificant,195–198
diagnosisof,197–198
echocardiographicconfirmationof,197–198,197f
managementof,198
pathophysiologiceffectsof,196,196f
historicalconsiderationsfor,755
nomenclature,755
normalclosureof,757–759,758f–759f
normalfetalcirculation,755
patent,interventionaltechniquesfor,268–269,269f
pathogenesisof,756–757
persistentlypatent,756–757,760f–762f
